Currently the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) represents the gold standard for assessment of structural damage in the spine of patients with axial spondyloarthritis (axSpA).
Gregory M. Weiss, M.D.
The established criteria for radiographic axial spondyloarthritis and axial spondyloarthritis that is classified as ankylosing spondylitis—is essentially the same, report physicians who recommend the interchangeable use of the terms "ankylosing spondylitis" and "radiographic axial spondyloarthritis."
New research shows that a newly identified species of gut bacteria is significantly depleted in patients with ankylosing spondylitis.
High levels of comorbidity burden are associated independently with poor physical function and increased disability in patients with psoriatic arthritis, however, patients ankylosing spondylitis did not report worse function when comorbidities were present.
Anne-Mari Mustonen and colleagues in Finland have determined the respective fatty acid (FA) signatures found in the infrapatellar fat pad (IFP) and synovial fluid (SF) of patients with osteoarthritis (OA), and rheumatoid arthritis (RA). While the authors’ findings are inconclusive, they give insight into the complex alterations in fatty acid profiles found in knee arthropathies. They present their findings in a recent Arthritis Research & Therapy.
The presence of carotid atherosclerosis in psoriasis and psoriatic arthritis patients is associated with an increased risk of having a cardiovascular event, researchers report.
Researchers writing in Arthritis Research & Therapy have outlined some factors that influence DNA methylation, also known as epigentics. In this slideshow, we highlight the factors.
What is nature's role in the development of inflammatory bowel disease, psoriasis and ankylosing spondylitis?
In an effort to determine what causes immune mediated diseases such as ankylosing spondylitis, inflammatory bowel disease and psoriasis, researchers have focused on learning more about genetic pathogenic pathways responsible for autoimmunity. In this article, we review the data and highlight best practices.
We have come a long way since the introduction of glucocorticoids for the treatment of systemic lupus erythematosus (SLE). But even with improved treatment and prognosis several challenges remain in the management of SLE. Here, we highlight the 10 most important challenges in treating patients with SLE.
While rituximab has proven to be an effective treatment for rheumatoid arthritis, it has failed to meet its primary endpoints in clinical trials for systemic lupus erythematosus (SLE). But now, an observational study suggests that rituximab could be effective as maintenance therapy in difficult SLE cases.